A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
The purpose of this study is to confirm that tasquinimod used as maintenance therapy is active and tolerable in patients with metastatic castrate-resistant prostate cancer not progressing after a first chemotherapy with docetaxel.
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
- 26 June 2024 - 1 mins read
The purpose of this study is to confirm that tasquinimod used as maintenance therapy is active and tolerable in patients with metastatic castrate-resistant prostate cancer not progressing after a first chemotherapy with docetaxel.
Related Clinical Trials
![Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
![Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
![Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
![Dysport® Pediatric Lower Limb Spasticity Follow-on Study Dysport® Pediatric Lower Limb Spasticity Follow-on Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
![Dysport® Adult Lower Limb Spasticity Follow-on Study Dysport® Adult Lower Limb Spasticity Follow-on Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
![Dysport® Pediatric Lower Limb Spasticity Study Dysport® Pediatric Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
![Dysport® Adult Lower Limb Spasticity Study Dysport® Adult Lower Limb Spasticity Study](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Study
![Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
![Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
![Dysport in the Treatment of Glabellar Lines in Chinese Subjects Dysport in the Treatment of Glabellar Lines in Chinese Subjects](https://www.ipsen.com/wp-content/themes/ipsen-main/dist/images/defaultImg.png)
26 June 2024
1 mins read